VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ERIC 2022 | Genomic tests available to patients with CLL at tertiary hospitals

Lukas Smolej, MD, PhD, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, Czech Republic, highlights genomic tests available to patients with chronic lymphocytic leukemia (CLL) at a tertiary hospital, including tests for IgHV and TP53 mutational status. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter